Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

No association between ACE polymorphism and risk of nasopharyngeal carcinoma.

Li ZH, Pan XM, Han BW, Han HB, Zhang Z, Gao LB.

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):210-5. doi: 10.1177/1470320311426168. Epub 2011 Nov 7.

PMID:
22064901
2.

Association of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in Taiwan.

Tsou YA, Tsai CW, Tsai MH, Chang WS, Li FJ, Liu YF, Chiu CF, Lin CC, Bau DT.

Anticancer Res. 2011 Oct;31(10):3629-32.

PMID:
21965789
3.

A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population.

Zhang Y, Zhang H, Zhai Y, Wang Z, Ma F, Wang H, Li P, Zhang Y, Yu L, Cui Y, He F, Zhou G.

BMC Med. 2011 Sep 20;9:106. doi: 10.1186/1741-7015-9-106.

4.

A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China.

Shao JY, Cao Y, Miao XP, Huang MY, Deng L, Hao JJ, Liang XM, Hu LF, Ernberg I, Lin DX, Zeng YX.

Chin J Cancer. 2011 Sep;30(9):620-6. doi: 10.5732/cjc.010.10592.

5.
6.

Current status of genome-wide association studies in cancer.

Chung CC, Chanock SJ.

Hum Genet. 2011 Jul;130(1):59-78. doi: 10.1007/s00439-011-1030-9. Epub 2011 Jun 16. Review.

PMID:
21678065
7.

Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma.

Zheng J, Zhang C, Jiang L, You Y, Liu Y, Lu J, Zhou Y.

Mol Carcinog. 2011 Sep;50(9):689-96. doi: 10.1002/mc.20803. Epub 2011 Jun 7.

PMID:
21656575
8.

Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension.

Ben Chaaben A, Busson M, Douik H, Boukouaci W, Mamoghli T, Chaouch L, Harzallah L, Dorra S, Fortier C, Ghanem A, Charron D, Krishnamoorthy R, Guemira F, Tamouza R.

Tissue Antigens. 2011 Aug;78(2):148-51. doi: 10.1111/j.1399-0039.2011.01702.x. Epub 2011 May 30.

PMID:
21623733
9.

XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries.

Laantri N, Jalbout M, Khyatti M, Ayoub WB, Dahmoul S, Ayad M, Bedadra W, Abdoun M, Mesli S, Kandil M, Hamdi-Cherif M, Boualga K, Bouaouina N, Chouchane L, Benider A, Ben-Ayed F, Goldgar D, Corbex M.

Mol Carcinog. 2011 Sep;50(9):732-7. doi: 10.1002/mc.20754. Epub 2011 Apr 22.

PMID:
21520294
10.

Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma.

Qin HD, Shugart YY, Bei JX, Pan QH, Chen L, Feng QS, Chen LZ, Huang W, Liu JJ, Jorgensen TJ, Zeng YX, Jia WH.

Cancer Res. 2011 Apr 15;71(8):3000-8. doi: 10.1158/0008-5472.CAN-10-0469. Epub 2011 Mar 2.

11.

Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.

Hassen E, Ghedira R, Ghandri N, Farhat K, Gabbouj S, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L.

DNA Cell Biol. 2011 Aug;30(8):603-9. doi: 10.1089/dna.2010.1140. Epub 2011 Feb 20.

PMID:
21332388
12.

Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.

Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G.

PLoS One. 2011 Feb 3;6(2):e16748. doi: 10.1371/journal.pone.0016748.

13.

Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese.

Li Y, Fu L, Wong AM, Fan YH, Li MX, Bei JX, Jia WH, Zeng YX, Chan D, Cheung KM, Sham P, Chua D, Guan XY, Song YQ.

PLoS One. 2011 Jan 20;6(1):e14562. doi: 10.1371/journal.pone.0014562.

14.

Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma.

Sousa H, Pando M, Breda E, Catarino R, Medeiros R.

Mol Carcinog. 2011 Feb;50(2):73-9. doi: 10.1002/mc.20689. Epub 2010 Dec 10.

PMID:
21229604
15.

Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma.

Yang ZH, Dai Q, Zhong L, Zhang X, Guo QX, Li SN.

Mol Carcinog. 2011 Mar;50(3):208-14. doi: 10.1002/mc.20706. Epub 2010 Dec 10.

PMID:
21154765
16.

Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.

Xu YF, Liu WL, Dong JQ, Liu WS, Feng QS, Chen LZ, Zeng YX, Zeng MS, Jia WH.

BMC Med Genet. 2010 Nov 11;11:161. doi: 10.1186/1471-2350-11-161.

17.

Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.

Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E.

Hum Immunol. 2011 Feb;72(2):150-8. doi: 10.1016/j.humimm.2010.10.006. Epub 2010 Oct 20.

PMID:
20969909
18.

Genetic risk markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha  -308G >A polymorphism.

Sousa H, Breda E, Santos AM, Catarino R, Pinto D, Medeiros R.

DNA Cell Biol. 2011 Feb;30(2):99-103. doi: 10.1089/dna.2010.1086. Epub 2010 Sep 28.

PMID:
20874489
19.

Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.

Cao Y, Miao XP, Huang MY, Deng L, Lin DX, Zeng YX, Shao JY.

Mol Carcinog. 2010 Nov;49(11):944-50. doi: 10.1002/mc.20676.

PMID:
20842669
20.

Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China.

Cao Y, Miao XP, Huang MY, Deng L, Liang XM, Lin DX, Zeng YX, Shao JY.

Mol Carcinog. 2010 Nov;49(11):928-34. doi: 10.1002/mc.20669.

PMID:
20721969

Supplemental Content

Support Center